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Spontaneous T  cell leukemias in AKR and HRS[J mice produce recombinant 
retroviruses that contain no known oncogene sequences (1), yet cause leukemia 
even  when  injected  into  mice  with  a  low  incidence  of the  disease  (2).  The 
transforming  mechanism  of these  viruses is  unknown,  but an  important  early 
event in the process is the binding of the viral envelope glycoprotein, gp70, to 
receptors of the target cell (3-7).  This interaction  most likely permits entry of 
the virus into the cell. Binding characteristics of retroviruses have been demon- 
strated  in  several  models (3-5,  8-10)  and  candidate  receptor  molecules have 
been isolated (11-16). 
Since each cloned leukemogenic recombinant retrovirus from AKR and HRS/ 
J  mice has a  unique  gp70  (2,  17,  18),  the  corresponding  gp70  receptors may 
possess individual binding specificities. It is therefore possible that a given thymic 
leukemia arises from a single target cell whose receptor binds specifically to the 
unique gp70 of a particular recombinant virus. The demonstration that a cloned 
leukemogenic virus induces T  cell leukemias with uniform surface phenotypes 
in  HRS/J  mice (19)  is consistent  with  this  idea.  Moreover,  McGrath  and  col- 
leagues (20,  21) have described a  thymic  leukemia that  binds preferentially  to 
the  retrovirus  it produces.  They suggest that  the retroviral  receptor of the T 
cell is actually an antigen-binding receptor and that leukemogenesis involves an 
immunoproliferative response to the novel glycoprotein (22). 
In the present experiments we attempted to identify leukemia cell membrane 
structures with specificity for recombinant gp70. The method we used was based 
on  the  hypothesis  that  the  virus-binding  sites  of retrovirus  receptors  share 
structural elements with the antigen-binding sites of anti-gp70 antibodies. Recep- 
tors that  share  binding  structures with antibodies against  hormonal  (23),  drug 
(24), neurotransmitter  (25), and viral (26-28) antigens have been described. In 
principle,  therefore,  an  antiidiotypic  antibody  against  an  anti-gp70  antibody 
could bind to cellular receptors for retroviral  gp70. Here we report the recog- 
nition of a structure on the surface of murine leukemia cells by an antiidiotypic 
antiserum  against an anti-retroviral  gp70 monoclonal antibody. This idiotype- 
like determinant was expressed on the surface of several murine thymic leukemias 
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as  well  as  on  leukemias  of B  cell  and  erythroid  lineage,  but  not  on  normal 
lymphoid cells. 
Materials and Methods 
Experimental  Animals.  CBA/J,  DBA/2J,  BALB/c, and  AKR/J  mice  were  obtained 
from The Jackson Laboratory, Bar Harbor, ME and were bred in our own animal facility. 
NFS/N mice were a  gift from the  National  Institutes of Health,  Bethesda,  MD.  NZW 
rabbits were obtained from Pine Acres Rabbitry, West Brattleboro, VT. 
Viruses.  Ecotropic, xenotropic, and polytropic retroviruses were isolated from HRS/J 
mice as previously described (29) and cloned by limiting dilution.  The three polytropic 
viruses  were  termed  P1,  P2,  and  P5.  Viruses  were  maintained  on  either  mink  lung 
epithelium (CCL64) or NIH-3T3 fibroblasts.  Purification of viruses  was accomplished by 
sucrose density gradient centrifugation (30) or Sepharose 4B (Pharmacia Fine Chemicals, 
Uppsala,  Sweden) column chromatography (31).  Titers of infectious polytropic viruses 
were determined by an immunofluorescent focus-forming assay on CCL64 cells (32). 
Antisera.  Goat antisera prepared against purified AKR gp70 and Tween-ether-dis- 
rupted Moloney virus were obtained from Dr. J. Cole, National Cancer Institute, Bethesda, 
MD. 
Cell Lines and Tumors.  Cell lines derived from 14 spontaneous AKR thymic ieukemias 
were a gift from Dr. Hiroshi Hiai, Aichi Cancer Center Research Institute, Nagoya,Japan. 
Cloned cell  lines from a  Friend virus complex-induced erythroleukemia (CL85) and an 
Abelson virus-induced pre-B cell  leukemia (298-18) were provided by Dr.  Stuart  Levy 
and  Dr.  Naomi Rosenberg, Tufts Cancer Research Center,  Boston,  MA.  All  cell  lines 
were maintained in Dulbecco's minimal essential  media (DMEM) ~  supplemented with 10% 
fetal calf serum (FCS). The pre-B cell medium also contained 5 ×  10  -5 M 2-mercaptoeth- 
anol.  Thymic leukemias  induced  by  P1  and  P2  (termed  P1  Thy and  P2  Thy)  were 
obtained from 8-12-mo-old CBA/J mice that were injected at birth with stocks of these 
cloned recombinant viruses (2). The ieukemias were propagated in vivo by intraperitional 
injection of 106 tumor cells into newborn CBA/J mice.  The NS-1 murine myeloma cell 
line  was used  for hybridizations.  It was maintained  in  DMEM  with  15%  FCS  and was 
treated twice with 8-azaguanine before use as a fusion partner. 
Preparation of an Anti-gp70 Monoclonal Antibody.  3-mo-old NFS/N mice were immu- 
nized by intraperitoneal injection with 107 P1 virus-infected NIH-3T3 cells emulsified in 
complete Freund's adjuvant (Difco Laboratories, Detroit, MI). Two subsequent immuni- 
zations with the cells in incomplete adjuvant were performed at 2-wk intervals.  The mice 
were boosted with 0.1  ml of concentrated virus (106 plaque-forming units/ml) 3 d before 
the hybridization. The hybridization was performed at room temperature according to 
the technique of Kohler and Milstein (33) with minor modifications. 
Identification  of Anti-Polytropic  Virus  1  (Anti-P1)  Monoclonal  Antibody.  An  enzyme- 
linked immunosorbent assay (ELISA) was used to detect antiviral antibodies. Immulon I 
plates (Dynatech Laboratories, Inc., Alexandria, VA) were coated with 100 #1 of a 10 #g/ 
ml solution of purified virus in phosphate-buffered saline (PBS), 0.02% sodium azide, pH 
7.2 (PBS-A), and incubated overnight at 4°C. The buffer was removed and the wells were 
blocked for 2 h at 37°C by the addition of 200 #1 of 5% bovine serum albumin in PBS 
(BSA-PBS-A). The BSA-PBS-A was replaced by 100 #1 of hybridoma supernatant and the 
plates  were incubated for 2 h at  37°C.  The supernatants  were removed and the wells 
were  washed  three  times  with  I%  BSA-PBS-A.  Then,  100  #1  of a  1:1500 dilution  of 
alkaline  phosphate-conjugated goat anti-mouse  IgG/IgM (Sigma  Chemical  Corp.,  St. 
Louis,  MO),  diluted  in  1%  BSA-PBS-A  was  added  to  each  well  and  the  plates  were 
l Abbreviations used in this paper:  BSA-PBS-A,  PBS containing bovine serum albumin and sodium 
azide; DMEM, Dulbecco's  minimum essential medium; ELISA,  enzyme-linked immunosorbent assay; 
FACS, fluorescence-activated cell sorter; FCS-PBS-A, PBA containing fetal calf serum and sodium 
azide; NP-40, Nonidet P-40; PBS-A, phosphate-buffered saline containing sodium azide, P1 Thy or 
P2  Thy,  P1  or  P2  virus-induced  thymic leukemia cells; SDS-PAGE, sodium dodecyl sulfate- 
polyacrylamide gel electropboresis; RIA, radioimmunoassay. ARDMAN,  KHIROYA, AND  SCHWARTZ  671 
incubated overnight at 4°C. The wells were then washed four times with  1% BSA-PBS- 
A and  100 el of substrate solution (20 ml 0.05 M NaHCOs, pH 9.5, 0.02 M MgCI~, and 
four substrate tablets [Sigma Chemical Co.]) was added to each well. The optical density 
(A4o5) was read on an ELISA spectrophotometer (Dynatech Laboratories, Inc.). 
Antiidiotypic  Antisera.  New  Zealand  White  rabbits were  immunized subcutaneously 
with an initial injection of 500 #g of anti-P1  gpT0 monoclonal antibody (referred to as 
1416) in complete Freund's adjuvant and subsequently boosted twice at 2-wk intervals 
with 500 #g of same antibody in an emulsion of incomplete adjuvant. The sera obtained 
were extensively absorbed on pooled mouse Ig (Cappei Laboratories, Cochranville, PA), 
followed by mouse IgG2a and IgG2b coupled to Sepharose 4B (Pharmacia Fine Chemi- 
cals). When no further protein could be eluted from these immunoadsorbants with 0.5 N 
acetic acid, the flow-through was adsorbed to and eluted from 5 mg of affinity-purified 
1416  coupled to Sepharose 4B.  The eluate was concentrated,  dialyzed against  PBS-A, 
and stored at 4°C until used. 
Radioimmunoassay  (RIA).  Two types of RIA were used: (a) an indirect RIA measured 
1416 idiotype binding to the antiidiotype, and (b) a competitive RIA measured Ig or virus 
inhibition of 1416 idiotype binding to the antiidiotype. For both types of RIA, polystyrene 
tubes (12 x  75 ram) were coated with 250 ng of the the antiidiotype in  100 #l of PBS-A, 
and incubated overnight at 4°C. The tubes were then blocked with 5% BSA-PBS-A for 
2 h at 37°C. For the indirect RIA, this step was followed by the addition of 100 #! of the 
idiotype (1416) or other Ig diluted in 1% BSA-PBS-A. The tubes were incubated for 6 h 
at 4°C, washed three times with  1% BSA-PBS-A, and  100 #1 of ~25I-labeled rabbit anti- 
mouse Ig (105 cpm) diluted in 1% BSA-PBS-A was added. After an overnight incubation 
at 4°C, the tubes were washed four times and counted in an Auto Gamma Counter 4000 
(Beckman  Instruments,  Inc.,  Fullerton,  CA).  All  determinations  were  performed  in 
triplicate. For the competitive RIA, two methods were used. In experiments to determine 
Ig inhibition  of idiotype  binding  to  the  antiidiotype,  50  #i  of ~25I-labeled  1416,  in  a 
concentration previously determined to be limiting for binding to the antiidiotype, was 
added to 50 #1 of Ig. This mixture was immediately added to antiidiotype-coated tubes 
that were prepared and blocked as stated above. After overnight incubation at 4 o  C, the 
tubes were washed four times with  1% BSA-PBS-A and counted.  For assays to evaluate 
virus inhibition of idiotype binding to antiidiotype, 100 ng of 1416 in 50 ~! 1% BSA-PBS- 
A  was preincubated  with  50  #1  of purified  virus  for  2  h  at  4°C.  The  antibody-virus 
mixture was then added to antiidiotype-coated tubes that were prepared and blocked as 
before. After incubation for 6 h at 4 o  C, the tubes were washed three times with 1% BSA- 
PBS-A, and 105 cpm of l~5I-labeled  rabbit anti-mouse Ig was added. The tubes were then 
incubated overnight at 4°C, washed four times, and counted. 
Immune Precipitation Assays.  Anti-P1  virus monoclonal antibodies were screened for 
binding  to  viral  gpT0  by immune  precipitation  with  both  radiolabeled  purified  virus 
preparations and membrane lysates from virus-infected cells.  For immune precipitation 
with viral proteins, 25 t~g of purified virus solubilized in PBS containing 0.5% Nonidet P- 
40 (NP-40) was radiolabeled with 0.6 mCi Na~5I (Amersham Corp., Arlington Heights, 
IL) using Iodobeads (Pierce  Chemical Co.,  Rockford, IL) according to the  method of 
Markwell (34). The solubilized virus preparation was precleared twice with normal mouse 
sera preadsorbed to Staph A (IgGsorb; The Enzyme Center, Inc., Boston, MA) and once 
with Staph A alone. 10 vg of affinity-purified antivirus monoclonal antibody was incubated 
overnight at 4°C with 2 x  106 cpm of the labeled virus lysate in a final volume of 100 ~1. 
80 #1 of a  10% Staph A suspension was then added for I h, followed by four pellet washes 
with 0.1%  BSA-PBS-A containing 0.5%  NP-40.  Immune precipitates were then eluted 
from the Staph A by incubation at 100°C for 5 min in sample buffer (0.06 M Tris-HCl, 
10% glycerol, 3% sodium dodecyl sulfate (SDS), 0.02% bromphenol blue, with or without 
5% 2-mercaptoethanol). 
For immune precipitation with cell membrane lysates, 2 x  107 cells were radiolabeled 
with 1.0 mCi Na~25I by the lactoperoxidase technique (35). Cells were washed four times 
before and immediately after labeling with ice-cold PBS, and then lysed in 300/A of 0.01 
M Tris-HCI, 0.15  M NaCI, 0.5%  NP-40, 2 mM phenylmethylsulfonyl fluoride, pH 7.0, 672  REACTION  OF  ANTI-(ANTI-gp70)  SERUM WITH  LEUKEMIA CELLS 
for V2 h on ice. The lysate was twice centrifuged at 13,000 rpm for 45 min at 4°C in an 
Eppendorf centrifuge (Brinkmann Instruments Co., Westbury, NY) to remove cellular 
debris.  The remaining supernatant was precleared and immune precipitated as above. 
When the antiidiotypic serum was  used to immune-precipitate radiolabeled membrane 
lysates,  preimmune rabbit serum and rabbit anti-mouse Ig were substituted for normal 
mouse serum in the preclearing procedure. 
Polyacrylamide Gel Electrophoresis (PAGE).  Immediately after elution from the Staph 
A,  the  immune  precipitates  were  analyzed by  PAGE  in  12.5%  acrylamide slab  gels, 
according to the method of Laemmli (36).  Gels were run at  150 V (constant voltage) at 
room temperature. Autoradiography was enhanced by the use of x-ray intensifying screens 
at -70°C. 
Virus Protein Blotting.  10 #g of purified P 1 virus was added to 40 ttl of sample buffer 
(with  5%  2-mercaptoethanol) and  heated for 5  rain at  100°C.  The sample was  then 
applied to a  12.5%  acrylamide slab  gel and  electrophoresis was  performed as above. 
Protein blotting was performed according to the method of Towbin et al. (37) for 4 h at 
250 mA onto 0.45-#m pore nitrocellulose paper (Schleicher & Schuell, Inc., Keene, NH). 
The paper was blocked with 3% BSA-PBS-A/0.5% NP-40 for 2 h at 4°C and then soaked 
in hybridoma supernatant overnight at 4 o  C, with slow, constant rotation. After six washes 
with 1% BSA-PBS-A/0.5% NP-40, the paper was soaked for 3 h at 4°C in a solution of 
l~5I-rabbit anti-mouse Ig (105 cpm/ml). The paper was then washed eight times as above, 
air dried, and autoradiographed for 24 h at -70°C with an x-ray intensifying screen. 
Immunofluorescent Flow Cytometry.  Murine leukemia cell lines and tumors were stained 
in suspension for analysis  with a fluorescence-activated cell sorter (FACS IV; B-D Auto- 
mated  Immunochemistry,  Becton,  Dickinson  & Co.,  Salt  Lake  City,  UT).  Cells  were 
washed twice with cold PBS, pH 7.2, containing 0.5% heat-inactivated FCS and 0.02% 
sodium azide (FCS-PBS-A),  and assayed for viability by trypan blue exclusion. Only cell 
suspensions demonstrating >90%  viability were used.  5  #g anti-P1  gp70  monoclonal 
antibody or 2.5 #g antiidiotype diluted in  50 #1 of FCS-PBS-A  were added to pellets 
containing 106 cells. The pellets were resuspended and incubated on ice for 30 min. Cells 
were washed once with cold FCS-PBS-A  and incubated as before with 50 ~1 of a  1:30 
dilution of fluorescein isothiocyanate-conjugated goat antiserum to mouse IgG (Meloy 
Laboratories, Inc., Springfield, VA) or rabbit IgG (Cappel Laboratories). The cell pellets 
were then washed once again  with  FCS-PBS-A  and  fixed in  1%  formaldehyde before 
FACS analysis. 
Results 
Characterization  of a Monoclonal Antibody to P1 gp70.  Previous work (2,  17, 
18,  38,  39)  has shown  that recombination within  the envelope (env) region of 
the  retroviral  genome  is  responsible  for  the  expression  of  novel  gp70s  in 
spontaneously generated leukemogenic viruses.  Distinct gp70s have been dem- 
onstrated in three recombinant leukemogenic retroviruses (P1, P2, and P5) and 
in two nonleukemogenic viruses (ecotropic and xenotropic) isolated from HRS/ 
J  mice (2). Hence, a  panel of these five purified viruses was used in a  screening 
assay to detect monoclonal antibodies with specificity for the leukemogenic virus 
P1.  Of all  the  antiretroviral  monoclonal  antibodies  that  were  obtained  after 
immunizing NFS/N  mice with  P1  virus-infected cells, one of them (1416) was 
found  to  bind  to  P1  virus  but  not  to  the  P2,  P5,  ecotropic,  and  xenotropic 
isolates (Fig.  1). 
This monoclonal antibody was further characterized by SDS-PAGE of immu- 
noprecipitates of lysates from radiolabeled purified virus, virus-induced thymic 
leukemia cells, and normal CBA/J thymocytes (Fig.  2). A  70,000 (70 K) tool wt 
protein was immunoprecipitated from P1 by 1416, but not from P2 or ecotropic ARDMAN,  KHIROYA,  AND  SCHWARTZ  673 
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FIGURE  1.  Binding of monoclonal antibody 1416 to different viruses. 1 #g of purified virus 
was used to coat  microtiter wells in polystyrene plates and an ELISA was performed.  The 
antibody bound only to the P1 virus. 
viral lysates (Fig.  2, a-c).  Fig.  2 d shows the proteins that were immunoprecipi- 
tated from purified P1 virus with goat anti-gp70 antiserum; the most prominent 
band corresponds to gp70. An 85 K mol wt protein was immunoprecipitated by 
1416 from the cell membranes of P 1 virus-induced  thymic leukemia cells (P 1 
Thy), but not from P2 Thy or from CBA/J thymocytes (Fig.  2, e-g).  A  protein 
of this molecular weight has been shown by others to represent either a precursor 
to  gp70  or  a  non-ionic  detergent-induced,  disulfide-linked  complex  between 
gp70 and the other viral envelope protein,  P15E (40). Western blot analysis of 
proteins from purified P 1 virus confirmed that the epitope recognized by 1416 
is present on the 70 K mol wt molecule (Fig. 2h). Fig. 2i demonstrates that the 
P2 virus does not contain a similar epitope. 
Characterization of an Antiidiotype Against Monoclonal Antibody 1416.  An anti- 
serum to antibody 1416 was raised by immunization of a rabbit. After extensive 
absorption  (see  Materials  and  Methods),  the  antiserum  from  this  animal  was 
found to recognize an idiotypic determinant of 1416. Fig. 3A illustrates that the 
antiidiotypic antiserum  did not bind to normal pooled mouse Ig,  normal  NFS 
mouse serum, or to the myeloma protein MOPC-195, which has the same isotype 
(IgG2b) as  1416.  Complete inhibition  of 1416 binding to the antiidiotype  was 
achieved with  1416 but not with MOPC-195, pooled mouse Ig, or NFS mouse 
serum, which contains Ig with the same allotypic determinants as 1416 (Fig. 3 B). 
The P 1 virus specifically inhibited the binding of 1416 to the antiidiotype (Fig. 
4).  In  the presence  of P 1 virus,  the idiotype-antiidiotype interaction  was com- 
pletely inhibited when we used a protein concentration of virus 100-fold greater 
than  that  of the idiotype. Identical  inhibition  was seen when purified P1  gp70 
was used as the inhibitor in 50-fold less quantities than the whole virus (data not 
shown). The specificity of the inhibition was shown by the failure of purified P2 
virus to inhibit the reaction. 
Binding of the Antiidiotype to Different Murine Leukemias.  Immunofluorescence 
flow cytometry was used to assay the antiidiotypic serum for its ability to bind to 
leukemia  cells.  We did  not  observe the  anticipated  pattern  of binding.  Even 674  REACTION  OF  ANTI-(ANTI-gp70)  SERUM WITH  LEUKEMIA CELLS 
FIGURE 2.  Binding  of 1416 to retroviruses and leukemic cells. NP-40 lysates of purified, 
radiolabeled virus were immunoprecipitated with 1416 and analyzed by SDS-PAGE under 
reducing conditions, (a) PI virus; (b) P2 virus; (c) ecotropic virus. NP-40 lysates of surface- 
iodinated leukemic or normal thymocytes were immunoprecipitated with 1416 and analyzed 
by SDS-PAGE under reducing  conditions. (e) P1  Thy; (f) P2  Thy; (g)  normal  CBA/J 
thymocytes. (d) Radiolabeled P1 virus that was immunoprecipitated with goat anti-Moloney 
virus antiserum. (h and i) Western blots of unlabeled purified P1  virus (h) and P2 virus (i) 
lysates that were reacted with 1416 and then ~51-1abeled rabbit anti-mouse  Ig. In this and 
subsequent gel electrophoreses, the numbers are molecular weight markers (Mr x  10-2). 
though the idiotype (1416) bound to P 1 and not to P2 virus (Fig.  1), and to P 1 
Thy and not to P2 Thy (Fig.  5B), the antiidiotype bound to both P1  Thy and 
P2  Thy  (Fig.  5A).  Possible  explanations  for the  results  with  the  antiidiotypic 
serum  include:  (a)  the  presence  of  two  or  more  antibody  populations  with 
different  antigen  specificities  in  the  antiidiotypic  serum;  (b)  binding  to  virus- 
encoded determinants present on the surface of both leukemias; and (c) recog- 
nition of a  determinant  that  is shared by both  P1  Thy and  P2  Thy. The first 
possibility  is  unlikely  because  the  antiidiotype  was  extensively  absorbed  with 
mouse Ig and then affinity purified on a  1416-Sepharose column (see Materials 
and  Methods).  Separate  absorptions  of  the  antiidiotype  with  four  different 
leukemia cell lines greatly reduced its reactivity with P1 Thy (Fig. 6A); moreover, ARDMAN,  KHIROYA,  AND  SCHWARTZ 
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FIGURE 3.  Binding of the  monoclonal anti-gp70 antibody  1416  to  the  antiidiotype. (A) 
Increasing amounts of 1416 or other mouse Ig were incubated in antiidiotype-coated  polysty- 
rene tubes. Bound Ig was detected with l~I-labeled rabbit anti-mouse Ig. For the NFS serum, 
the concentrations represent calculated amounts of the lgG2b isotype. (B) Increasing amounts 
125  $  of inhibitor proteins were mixed with 60 ng of  I-labeled 1416 (sp act, 5 ×  10  cpm/ng) and 
the mixture was added to antiidiotype-coated polystyrene tubes. The percentage of bound 
1416 is represented on the ordinate. 
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FIGURE 4.  Inhibition of the  reaction of  1416  with  the antiidiotype by  virus.  Increasing 
amounts of purified virus were incubated for 2 h at 4°C with 100 ng of 1416. The virus-1416 
mixture was then added to antiidiotype-coated tubes and the amount of bound  1416  was 
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FIGURE 5.  Fluorescence flow cytometry of the binding of antiidiotype and 1416 to normal 
and leukemic thymocytes. (A) Indirect immunofluorescence  of 20,000 cells stained with 2.5 
ug of affinity-purified antiidiotype (- - -) or 2.5 #g of affinity-purified control rabbit Ig 
(  .  ). (B) Indirect immunofluorescence  of 20,000 cells stained with 5 #g of affinity-purified 
1416 (- - -) or 2.5 •g  of affinity-purified  MOPC-195 (  ). Note that the antiidiotype  reacted 
with P2 Thy, whereas 1416 did not (compare with Fig. 2, e and f). Neither the antiidiotype 
nor 1416 reacted with normal thymocytes  (compare with Fig. 2 g and Fig. 7 b). 
antiidiotype that was absorbed  with P1  Thy cells lost its ability to bind to the 
1416 idiotype, whereas absorption with normal CBA/J thymocytes did not affect 
its  ability to  bind  to  the  1416  idiotype (Fig.  6B).  The  second  possibility was 
excluded by immunoprecipitation studies as shown below. 
The third possibility was explored by testing the reactivity of the antiidiotype 
with a  panel  of different murine  leukemia  cell  lines.  14  spontaneous  thymus 
leukemias from different AKR/J mice, one Abelson virus-induced "pre-B" cell 
leukemia (298-18), and one Friend virus complex-induced erythroleukemia (CL- 
85) were examined for antiidiotype binding by flow cytometry. Results of these 
experiments (Table I, column A) showed that the antiidiotype bound to several 
leukemia cell  lines, including both T  cell and non-T cell leukemias. A  control 
preparation  of normal  rabbit  Ig demonstrated no  binding.  Normal  lymphoid 
cells from the murine strains in which these ieukemias were induced did not bind 
to the antiidiotype. Normal CBA/J thymocytes that were stimulated for either 
48  or 96  h  with concanavalin A  (1  #g/(106  cells, mi) also failed to bind to the 
antiidiotype, indicating that the idiotype-like structure  was not a  proliferation 
antigen. 
The idiotype (1416) also bound to some of these leukemia cell lines (Table I, 
column  B).  lmmunoprecipitation  and  SDS-PAGE  analysis of [~5S]methionine- 
labeled AKR leukemia cell  lysates confirmed that the structure  recognized by 
1416 was an 85  K  mol wt protein (data not shown). Thus, an epitope common 
to the gp70 precursor of several of these independently derived tumors was also 
expressed on P1  Thy. Yet, as seen with P2 Thy, AKR 21, AKR 71, and pre-B 
298-18,  the  lack  of expression  of this  epitope  (Table  I,  column  B)  did  not 
preclude expression of the structure that crossreacted with the anti-gp70 idiotypic ARDMAN, KHIROYA, AND  SCHWARTZ  677 
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FIGURE 6.  Binding  of absorbed antiidiotypic antiserum to P1 Thy and 1416. (A) 50 tA of 
antiidiotypic  antiserum was absorbed three times with 20 x 10  ~ normal or leukemic cells and 
then tested for binding to P 1 Thy. Binding was detected with ]~SI-labeled  goat anti-rabbit Ig. 
Unabsorbed antiidiotype reactivity with P1  Thy was assigned 100% binding. (B) Identical 
absorptions of the antiidiotypic  serum were performed with either normal CBA/J thymocytes 
or P1 Thy, followed  by a test for binding to 1416. 
determinant (Table I, column A). Therefore, the anti-gp70 antibody (1416) and 
the antiidiotype reacted with different determinants on the leukemia cell surface. 
Immunoprecipitation  of the  Idiotype-like  Structure from  Cell  Membranes.  The 
structure(s) recognized by the anti-(anti-gp70) idiotypic serum was further ana- 
lyzed by  immunoprecipitation of membrane  lysates from  surface-radiolabeled 
leukemia cells. All lysates were precleared twice with a preimmune rabbit serum- 
Staph A  complex, once with a rabbit anti-mouse Ig/Staph A complex and once 
with Staph A alone. The immunoprecipitates were analyzed by SDS-PAGE under 
reducing conditions. Fig. 7 A demonstrates that the antiidiotype failed to immu- 
noprecipitate  proteins  from  normal  CBA/J  thymocyte  membranes  (lane  b), 
whereas anti-Moloney virus antiserum immunoprecipitated several proteins (lane 
a). These proteins most likely represent endogenous ecotropic gag and env gene 
products.  The  anti-Moloney virus antiserum also  immunoprecipitated several 
proteins  from  P1  Thy  membranes  (Fig.  7B,  lane  c)  that  are  probably  gene 
products of endogenous ecotropic or xenotropic viruses as well as the P 1 virus. 
Neither  rabbit  anti-mouse  Ig  (Fig.  7B,  lane  b)  nor  preimmune  rabbit  serum 
(lane a)  immunoprecipitated any proteins  from the  P1  Thy membranes.  The 678  REACTION  OF  ANTI-(ANTI-gp70) SERUM  WITH  LEUKEMIA CELLS 
TABLE  I 
Binding of Antiidiotype and Idiotype to Normal and Leukemic Cells 
Source of cell 
Fluorescence* 
A. Antiidi-  B. Idiotype  otype 
Normal (4 wk old) 
CBA/J thymus  3  0 
CBA/J thymus (Con A stim.)*  3  0 
CBA/J lymph node  1  0 
CBA/J spleen  3  0 
BALB/c thymus  0  0 
BALB/c lymph node  1  0 
BALB/c spleen  0  0 
DBA/2J thymus  0  0 
DBA/2J lymph node  1  0 
DBA/2J spleen  1  0 
AKR thymus  2  0 
Leukemic 
P1 Thy  18  26 
P2 Thy  32  0 
Pre-B 298-18  51  0 
Erythroleukemia CL85  35  0 
AKR-18  14  10 
AKR-21  41  0 
AKR-29  8  20 
AKR-52  2  10 
AKR-65T  9  t 1 
AKR-65I  50  0 
AKR-67  34  0 
AKR-69  24  5 
AKR-70  11  22 
AKR-71  66  0 
AKR-75  15  9 
AKR-79  7  16 
AKR-89  10  0 
AKR-92  40  1 
* All values represent  AMCF (median  channel  fluorescence  of test anti- 
body -  median channel fluorescence of control antibody). 
* Normal CBA/J thymocytes stimulated  in vitro with concanavalin  A (1 
ug/10  n cells/ml) for 48 h. 
absence of bands in  Fig.  7B,  lane b verifies the completeness of the preclearing 
procedure. 
Fig.  7 C demonstrates  that the antiidiotype did not react with cell-bound Ig or 
virus-encoded proteins.  Labeled  P1  Thy membrane  lysates precleared as above 
were further precleared three times with the goat anti-Moioney virus antiserum 
and then immunoprecipitated  with the antiidiotypic serum. The completeness of 
the viral protein  preclearing  procedure  was verified by the absence of bands in 
Fig.  7 C, lane b, where the precleared  lysate was immunoprecipitated  with anti- ARDMAN, KHIROYA, AND  SCHWARTZ  679 
FIGURE 7.  SDS-PAGE analysis of cell surface proteins from normal and leukemic CBA/J 
thymocytes. Cells were surface iodinated and lysed in a buffer containing 0.5% NP-40. (A) 
Thymocyte membrane proteins from normal 4-wk-old CBA/J mice that were immunoprecip- 
itated with the antiidiotype (lane b) or goat anti-Moloney virus antiserum (lane a). (B) PI 
thymic leukemia cell membrane proteins that were precleared with normal rabbit serum and 
rabbit anti-mouse  Ig and then immunoprecipitated with preimmune rabbit serum (lane a), 
rabbit anti-mouse  Ig (lane b), or goat anti-Moioney virus antiserum (lane c). (C) P1 thymic 
leukemia cell membrane proteins that were further precleared with goat anti-Moloney virus 
antiserum and then immunoprecipitated with the antiidiotypic antiserum (lane a) or the goat 
anti-Moloney virus antiserum (lane b). 
Moloney virus antiserum. By contrast, three bands with molecular weights of 70, 
63,  and  55  K  were  found in  the  precleared  lysates of P1  Thy cells that  were 
immunoprecipitated  with  the antiidiotype  (Fig.  7 C,  lane  a).  Experiments  with 
lysates  from  surface-labeled  P2  Thy  cells  yielded  identical  results  (data  not 
shown). 
Three other leukemia cell lines (pre-B 298-18,  Friend CL-85, AKR-71) were 
also surface-labeled with  125I and the cell lysates immunoprecipitated as above. 
Protein bands common to all three leukemias were found in the lanes containing 
the antiidiotype immune precipitates (Fig.  8); as with the P1  Thy cells,  70 and 
55  K  mol  wt  proteins  were  also  precipitated  from  these  three  leukemia  cell 
lysates (Fig. 8, lanes d, h, l) and the 63 K mol wt protein was seen in two of them. 
A less prominent 25 K moi wt band in these three leukemia lines was not detected 
in  the  P1  Thy immunoprecipitates.  Several other bands were noted in  Fig.  8, 
lanes  d,  h,  and  l;  the  possibility  that  all  or  some  of these  were  the  result  of 
coprecipitation remains to be clarified. 680  REACTION  OF  ANTI-(ANTI-gp70)  SERUM  WITH  LEUKEMIA  CELLS 
FIGURE 8.  SDS-PAGE analysis of cell surface proteins from three unrelated leukemias: 298- 
18, a pre-B cell leukemia; CL85, an erythroleukemia; and AKR 71, a thymic leukemia. The 
leukemic cells were surface iodinated and lysed in a buffer containing 0.5% NP-40. Immuno- 
precipitation was performed with the following reagents: anti-Moloney virus antiserum (a, e, 
and i), preimmune rabbit serum (b, f, j), rabbit anti-mouse Ig (c, g, k), and the antiidiotypic 
serum (d, h, l). 
Discussion 
Retroviral  binding  structures  on  normal  murine  lymphoid cells  have  been 
studied by several investigators. Twardzik et ai. (11) demonstrated six proteins 
with molecular weights ranging from 26 to 170 K that were coprecipitated with 
Rauscher  murine leukemia virus gp70  by treatment of a  BALB/c  thymocyte 
membrane-virus mixture with a  bifunctional crosslinking chemical and  immu- 
noprecipitation with anti-gp70 antiserum. Schaffar-Deshayes et al. (14) found a 
190  K protein on BALB/c thymocyte membranes that coprecipitated with the 
Moloney virus gp70, using an anti-gp70 serum without prior crosslinking. With 
a similar technique, Robinson et al.  (15) detected a  14 K protein on C57BL/6 
mouse spleen cell membranes that bound a  Friend virus glycoprotein complex 
(gp85).  We have performed similar experiments with thymic leukemias. In our 
hands, however, pretreatment of cell membranes with a bifunctional crosslinking 
chemical followed by immunoprecipitation with a monoclonal anti-gp70 antibody 
only occasionally yielded cellular proteins distinct from endogenous gp85.  We 
also found that without the use of a crosslinking reagent, no proteins coprecipi- 
tated with gp85 (unpublished data). ARDMAN, KHIROYA, AND SCHWARTZ  681 
Because of  our lack of  success with this technique, we used a different approach, 
based on the idea that cell surface receptors can share binding determinants with 
anti-ligand antibodies (23-28).  In retrovirus-induced murine T  cell leukemia, 
the viral envelope glycoprotein gp70 serves as the ligand to which the target cell 
receptor binds. Hence, the variable region of  an anti-gp70 antibody may resemble 
the binding region ofa retroviral receptor. In principle, therefore, the combining 
sites of both the receptor and the antibody may be identified by an appropriate 
antiidiotypic antibody. 
A  monoclonal antibody that  recognized the gp70  of a  cloned recombinant 
leukemogenic polytropic retrovirus termed P1  was  the starting  point  for the 
present experiments. This antibody (1416) was selected because it failed to react 
with endogenous ecotropic and xenotropic viruses, and it did not bind to two 
other recombinant viruses, P2 and P5, with structurally different gp70s (2).  In 
subsequent studies, however, we found that 1416 was reactive with several other 
virus-induced leukemia cell lines (Table I). Thus, despite its specificity for the 
gp70 of the P1  virus, this monoclonal antibody crossreacted with other retrovi- 
ruses, presumably because of shared epitopes in their gp70s. 
Antibody  1416  was  used to  prepare a  rabbit  antiidiotypic antiserum.  This 
antiserum reacted with structures in or near the antigen-binding site of 1416, as 
determined by inhibition of the idiotype-antiidiotype reaction by the P1  virus 
(Fig. 4). The inhibition was specific, as another cloned leukemogenic polytropic 
retrovirus (P2) did not affect the reaction. 
The antiidiotypic reagent failed to react with normal murine lymphoid cells 
when it was tested by both immunofluorescence and immunoprecipitation meth- 
ods.  Furthermore, mitogenic stimulation of thymocytes from 4-wk-old normal 
CBA/J mice failed to induce a  significant expression of the idiotype-like deter- 
minant, suggesting that it is not a  widely expressed proliferation antigen. The 
failure of the antiidiotype to  react with  normal  thymocytes suggests that  the 
idiotype-like structure we found is leukemia specific. Alternatively, the structure 
might occur on  only a  few undetectable normal cells that are targets for the 
retrovirus.  After  infection  and  transformation,  such  cells  would  increase  in 
number and thus become readily detectable in the leukemia cell population. 
The antiidiotypic serum reacted with a structure on the surface of a  murine 
thymic leukemia (P1  Thy) that was induced by the retrovirus (P1) against which 
the anti-gp70 antibody (1416) was raised. This membrane determinant, however, 
was also found on several different murine leukemias, irrespective of the serolog- 
ical  relatedness  of their  expressed  retroviral  glycoproteins  to  P1  gp70.  For 
example, the leukemia cell lines pre-B 298-18,  AKR-65I, and AKR-71  reacted 
strongly with the antiidiotype, but failed to bind to 1416 (Table I). 
The data thus indicate that the membrane structure detected by the antiidi- 
otype is not virally encoded. Additional evidence against its viral origin is the 
failure of an anti-Moloney virus antiserum (which crossreacted with  P1  viral 
proteins)  to  eliminate the  structure  from  labeled  P1  Thy membrane lysates, 
whereas  the  same antiserum  removed most  virus-encoded proteins  from  the 
lysates (Fig.  7C).  The determinant is  not an artifact caused by adsorption  of 
mouse Ig to the surface of the murine leukemia cells that had been passed in 
vivo; it was found not only on leukemia cells obtained ex vivo (P1  Thy, P2 Thy) 682  REACTION  OF  ANTI-(ANTI-gp70)  SERUM  WITH  LEUKEMIA  CELLS 
but also  on  leukemia cell  lines  maintained exclusively in  vitro.  Furthermore, 
membrane lysates of labeled leukemia cells that were precleared with rabbit anti- 
mouse Ig still contained the idiotype-bearing structure (Figs.  7 C, 8). 
If  the  anti-(anti-gp70)  idiotype  we  describe  indeed  identifies  a  retroviral 
receptor, then receptors for different leukemogenic viruses may share common 
structures. This possibility is strengthened by the finding that different leukemia 
cell lines, regardless of their lineage or causative retrovirus, expressed a similar 
membrane structure. However, since Ig with different binding specificities are 
known to share idiotypes (41, 42), it is possible that the binding specificities of 
gp70  receptors may be unique despite their shared reactions with the antiidi- 
otype. The polyclonal antiidiotypic serum used in our experiments increased the 
likelihood that a family of idiotypic determinants, rather than a single idiotope, 
was recognized. It is also possible that the antiidiotype was an "internal image" 
(homobody) (43) of the gp70 of P1, but only to an approximation, so that the 
specific features of the  recombinant gp70  were imprecisely mirrored by  the 
binding site of the antiidiotype. The above factors could explain the broad range 
of reactivity among the several leukemias examined with the antiidiotype. Hence, 
the concept that retroviral receptors share common structures and yet possess 
unique virus-binding specificities is not internally inconsistent. 
McGrath et al. (28) have also studied receptors for retroviruses on leukemic 
cells. They found that the surface IgM of a murine B cell lymphoma bound to a 
ieukemogenic retrovirus, and that antibodies against the idiotype of the surface 
IgM inhibited its binding to the virus.  Fluorescence analysis indicated that the 
idiotype of the B cell lymphoma was also present on two T  cell lymphomas. 
Nepom et ai.  (26) showed that an anti-reovirus hemagglutinin idiotype was 
shared by lymphoid and nonlymphoid (neural) cells, both of which are targets of 
the  reovirus.  In  the  same system,  Kauffman et  al.  (44)  demonstrated that  a 
monoclonal anti-antihemagglutinin idiotypic antibody is capable of blocking virus 
binding to idiotype-positive cells. 
If anti-(anti-gp70)  idiotypic antibodies  are  capable  of binding  to  retroviral 
receptors in  vivo,  then  interference with  primary infection, subsequent  viral 
propagation, or inhibition of leukemia cell proliferation may be anticipated. The 
binding  of antiidiotypic antibodies  to  retroviral  receptors  might  also  initiate 
mitogenic signals similar to those postulated for gp70, and result in lymphoblastic 
transformation (17, 45), lymphokine sensitivity (46), or both. Inhibition of virus 
binding to a  murine thymoma by monoclonal anti-T cell antibodies has been 
shown  to  prevent  tumor  cell  proliferation  in  vitro  (47).  Those  antibodies, 
however, were not specific for leukemia cells but bound to normal T  cell antigens 
such  as  Thy-1.  The  effects of antiidiotypic reagents on  these processes  may 
provide insights into the specific events involved in viral leukemogenesis at the 
level of the cell membrane. Finally, diagnostic application of the kind of antiidi- 
otype we have described, a topic currently under investigation, could lead to a 
novel way of identifying leukemic cells. 
Summary 
The possibility that receptors for retroviral gp70  share structural  elements 
with the antigen-binding sites of anti-retroviral gp70 antibodies was investigated. ARDMAN, KHIROYA, AND  SCHWARTZ  683 
A  monoclonal antibody (1416)  was produced  that  reacted with  the gp70  of a 
cloned recombinant leukemogenic retrovirus, termed P1. An antiidiotypic anti- 
serum raised to  1416  was tested for its ability to bind to the thymic leukemia 
induced by P1 (P1 Thy). A  membrane structure was identified on the surface of 
P 1 Thy that reacted with the antibody against the idiotypic determinant of 1416. 
A  similar structure was identified on the surface of several different, independ- 
ently derived murine  leukemias  of T  cell,  B  cell,  and  erythroid lineage.  The 
expression  of the  idiotype-like determinant  on  these  leukemia  cells was  inde- 
pendent  of the  serological  relatedness  of their  expressed  retroviral  envelope 
glycoproteins to P1  gp70.  The determinant recognized by the antiidiotype was 
not detected on normal lymphoid cells. The recognition by the anti-(anti-gp70) 
idiotype of determinants on unrelated murine leukemias suggests that receptors 
for different leukemogenic viruses may share common structures. 
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